Stat | Value |
---|---|
Share Price (delayed ~1 day) | $0.073 |
Analyst Valuations | $2.00 - $2.00 (from 1 Analysts) |
EPS | -$0.112 |
PE | 0 |
Dividend Yield | 0 |
Average Daily Volume | 440,047 shares / $32,123 |
Market Cap | $20.6m |
Shares on Issue | 236.3m |
Listing Date | 1994-09-01 |
Similar/Popular Websites | Biotechdispatch.com.au, Novogene.com |
Common Search Phrases | Kazia, Kazia Therapeutics, Novogen, Gbm Ceo, Gdc-0084 |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences |
Stat | Value |
---|---|
Share Price (delayed ~1 day) | $0.315 |
Analyst Valuations | $1.36 - $3.10 (from 2 Analysts) |
EPS | -$0.184 |
PE | 0 |
Dividend Yield | 0 |
Average Daily Volume | 954,710 shares / $300,734 |
Market Cap | $110.6m |
Shares on Issue | 351.2m |
Listing Date | 2015-08-19 |
Similar/Popular Websites | Brightonspinal.com.au, Paradigm-uk.org, Paradigm050.com, Paradigmdx.com |
Common Search Phrases | Paradigm, Par Asx, Aus Biopharm, Paradigm Company, Marital Complexity Paradigm |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences |
Metric | Change |
---|---|
Share Price | $0.073 to $0.073 (+0.00%) |